Taspoglutide

CAS : 275371-94-3

Ref. 3D-ALA37194

Informations sur le produit

• Nom: Taspoglutide
• Synonymes: Taspoglutide [USAN], Bim 51077, Itm 077, R 1583, Ro 5073031, Ro5073031, 7-36-Glucagon-like peptide I (human), 8-(2-methylalanine)-35-(2-methylalanine)-36-L-argininamide-, H2N-His-2-methyl-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-2-methyl-Ala-Arg-CONH2

Description

Taspoglutide is a novel insulinotropic agent that belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. It increases the level of glucagon-like peptide 1 (GLP-1) by inhibiting DPP-4, an enzyme that breaks down GLP-1. Taspoglutide is used for the treatment of type 2 diabetes and has shown long-term efficacy in clinical trials. Taspoglutide has been shown to have an excellent pharmacokinetic profile and does not affect glucose metabolism in healthy subjects.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 3,339.71 g/mol
• Formule: C₁₅₂H₂₃₂N₄₀O₄₅
• Degré de pureté: Min. 95%